Exabis Library
Welcome to the e-CCO Library!
P315 Short-chain fatty acid profile in inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P315: Effect of age on beliefs about and adherence to medications in patients with inflammatory bowel disease: results from the ALIGN study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P315: Gastrointestinal immune related adverse events associated with programmed-Death 1 blockade
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P315: High symptom burden and impact on health-related quality of life in patients with Crohn’s perianal fistulas: results from a global burden of illness study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P315: Molecular screening for Lynch syndrome in IBD colorectal cancer
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P315: Population pharmacokinetics and pharmacodynamics of ozanimod in ulcerative colitis
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P315: Systemic and tissue modulation of IL-23 pathway biomarkers in a Phase 2 study of risankizumab in patients with Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P315: The characteristics and severity of pediatric ulcerative proctitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P316 Hepatobiliary manifestations measured by vibration-controlled transient elastography in inflammatory bowel disease: A prospective hospital-based cohort study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P316: A study on the impact of diagnosis on the level of exercise amongst patients with IBD
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P316: Human neutrophil elastase derived fragment of calprotectin (S100a9) is a serum biomarker (CPa9-HNE) for monitoring of anti-TNFα treatment response in Crohn’s disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P316: Inflammatory Bowel Disease and malignancy: What are the predictors of malignancy in Inflammatory Bowel Disease?
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P316: New approaches for IBD management based on text mining of digitalised medical reports and latent class modelling
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P316: Ozanimod is an efficacious oral therapy after 5-ASA failure in immunomodulator- and biologic-naive patients with ulcerative colitis: post hoc analysis from True North
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P316: Prognosis of patients with inflammatory bowel disease in clinical remission after de-escalation of infliximab maintenance therapy from 8 to 12 weeks
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P316: Transanal minimal invasive proctectomy (TaMIP) for perineal Crohn’s disease; a multi-centre prospective cohort study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P317 Key features of bowel ultrasonography in managing inflammatory bowel disease patients
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P317: Characterisation of patients with delayed response to ustekinumab for Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P317: Health care costs associated with standard inflammatory bowel disease care in Australia and opportunities to improve care: a tertiary centre study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P317: MaRIA score in the assessment of disease activity in patients with ileocolonic Crohn’s disease; the correlation between radiological, endoscopic, and clinical findings
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM